VentriPoint Diagnostics (VPT) Insider Trading & Ownership C$0.14 +0.01 (+3.85%) As of 04/17/2025 03:56 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisChartHeadlinesInsider TradesBuy This Stock VentriPoint Diagnostics (CVE:VPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.13%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)C$33,449.50Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)C$1,202.32 Get VPT Insider Trade Alerts Want to know when executives and insiders are buying or selling VentriPoint Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VPT Insider Buying and Selling by Quarter VentriPoint Diagnostics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2024Victor Johan HugoSenior OfficerSell12,656C$0.10C$1,202.325/2/2024Hugh MacnaughtDirectorBuy20,000C$0.22C$4,420.004/26/2024Robert HodgkinsonDirectorBuy4,500C$0.21C$945.004/24/2024Robert HodgkinsonDirectorBuy21,000C$0.21C$4,410.004/22/2024Robert HodgkinsonDirectorBuy75,000C$0.21C$15,900.004/18/2024Robert HodgkinsonDirectorBuy36,500C$0.21C$7,774.50 (Data available from 1/1/2013 forward) VPT Insider Trading Activity - Frequently Asked Questions Who is on VentriPoint Diagnostics's Insider Roster? The list of insiders at VentriPoint Diagnostics includes Hugh Macnaught, Robert Hodgkinson, and Victor Johan Hugo. Learn more on insiders at VPT. What percentage of VentriPoint Diagnostics stock is owned by insiders? 2.13% of VentriPoint Diagnostics stock is owned by insiders. Learn more on VPT's insider holdings. Which VentriPoint Diagnostics insiders have been buying company stock? The following insiders have purchased VPT shares in the last 24 months: Hugh Macnaught (C$8,820.00), and Robert Hodgkinson (C$29,029.50). How much insider buying is happening at VentriPoint Diagnostics? Insiders have purchased a total of 177,000 VPT shares in the last 24 months for a total of C$37,849.50 bought. Which VentriPoint Diagnostics insiders have been selling company stock? The following insider sold VPT shares in the last 24 months: Victor Johan Hugo (C$1,202.32). How much insider selling is happening at VentriPoint Diagnostics? Insiders have sold a total of 12,656 VentriPoint Diagnostics shares in the last 24 months for a total of C$1,202.32 sold. VentriPoint Diagnostics Key ExecutivesDr. George Adams B.A.Sc. (Age 76)ICD.D., M.A.Sc., Ph.D., Executive Chairman & Corporate Secretary Compensation: $286kMr. Hugh MacNaughtInterim CEO, President & DirectorMr. Jimmy JeonChief Financial OfficerMr. Hirotaka KatagiriCTO & Business Development Division DirectorMatt DobsonMarketing DirectorMr. Jim GrabaApplication Specialist & Chief TrainerMr. Bart HendriksStrategic Partnership Executive More Insider Trading Tools from MarketBeat Related Companies Aurora Spine Insider Ownership Medicenna Therapeutics Insider Ownership Sernova Insider Ownership Theratechnologies Insider Ownership Oncolytics Biotech Insider Ownership Medexus Pharmaceuticals Insider Ownership Microbix Biosystems Insider Ownership KDA Group Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (CVE:VPT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VentriPoint Diagnostics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share VentriPoint Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.